Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HALT PKD A: RAAS Blockade and BP Targets in Early ADPKD
NCT00283686Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jan 2006
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan in autosomal dominant polycystic kidney disease (ADPKD), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jan 2006; status: completed.
02
Drugs
telmisartan
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT00283686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00283686.